The plaintiffs in the Risperdal mass tort litigation have asked a Philadelphia judge to reconsider his decision last month barring them from seeking punitive damages in any of their cases.
In a May 2 order in In re Risperdal Litigation, Philadelphia Court of Common Pleas Judge Arnold New said in a footnote that New Jersey law applies to the plaintiffs’ claims alleging Janssen Pharmaceuticals engaged in off-label marketing of Risperdal to children that resulted in alleged damages that included boys developing breasts as a result of taking the drug.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
